Key terms
About ASRT
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ASRT news
Apr 03
8:15am ET
Assertio Holdings appoints Sig Kirk to board of directors
Apr 02
5:23pm ET
Assertio Holdings Chairman Declines Reelection Amid Disputes
Mar 12
8:43am ET
Assertio Holdings price target lowered to $3 from $4 at Lake Street
Mar 11
5:34pm ET
Assertio Holdings files $150M mixed securities shelf
Mar 11
5:22pm ET
Assertio Therapeutics Welcomes Sigurd Kirk to Board
Mar 11
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 11, 2024
Feb 29
7:01pm ET
SHAREHOLDER ALERT: Potential Recovery for Assertio Holdings, Inc. (ASRT) Investors
Feb 24
10:14am ET
Assertio Therapeutics Faces Potential Nasdaq Delisting Threat
Jan 27
4:31am ET
Assertio Holdings Announces CEO’s Immediate Board Resignation
Jan 08
5:35pm ET
SHAREHOLDER ALERT: Potential Recovery for Assertio Holdings, Inc. (ASRT) Investors
ASRT Financials
Key terms
Ad Feedback
ASRT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ASRT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
